Silvando Carmo de Oliveira

Silvando Carmo de Oliveira

Auto-generated profile, based on publicly available information

Silvando Carmo de Oliveira

Universidade Federal do Ceará

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2026 in Mastology
Verified
Journal Article
Open access
PDF file
ECEmmanuel Filizola Cavalcante
Emmanuel Filizola Cavalcante
JLJose Juvenal Linhares
Jose Juvenal Linhares
LRLuciana Gomes da Rocha
Luciana Gomes da Rocha
SOSilvando Carmo de Oliveira
Silvando Carmo de Oliveira
FMFernando Daniel de Oliveira Mayorga
Fernando Daniel de Oliveira Mayorga
Diane Isabelle Magno CavalcanteDiane Isabelle Magno Cavalcante
Diane Isabelle Magno Cavalcante
Introduction: Fine-needle aspiration or core needle biopsy guided by ultrasound of the axilla can provide crucial information for the treatment of breast cancer. Methods: This prospective phase 1 real-world study evaluated the effectiveness of the triple test, physical examination (PE), ultrasound (US), and ultrasound-guided fine-needle aspiration (USFNA) or ultrasound-guided core needle biopsy (USCNB) in predicting axillary metastases. It also explored the possibility of omitting axillary surgery based on negative results. The study included patients with high-penetrance mutations, ductal carcinoma in situ, or invasive breast cancer (cT1–4, axillary cN0–2), all of whom underwent aspiration or biopsy along with lymph node marking (using charcoal or clips), followed by sentinel lymph node biopsy and/or axillary dissection. Results: A total of 363 lymph nodes were dissected in 43 patients. The sensitivity of PE and US was 33.3% and 53.3%, respectively. When combining USFNA/USCNB with PE and US, sensitivity increased from 66.67% to 80%. Among patients with mutations or ductal carcinoma in situ or invasive cancer (cT1–4), when all three methods (PE, US, and USFNA/USCNB) were negative, the rate of positive lymph nodes was only 10%. Conclusions: Relying solely on PE, US, or USFNA/USCNB has limitations in detecting axillary metastases. Incorporating USFNA/USCNB significantly improved sensitivity and decreased false-negative rates. When all three methods were negative, the rate of axillary involvement was only 10%, indicating that axillary surgery could potentially be omitted. However, further studies are needed to validate these methods as reliable predictive tools for treatment decisions.

7 April 2026 in Mastology
Verified
Journal Article
Open access
ECEmmanuel Filizola Cavalcante
Emmanuel Filizola Cavalcante
JLJose Juvenal Linhares
Jose Juvenal Linhares
LRLuciana Gomes da Rocha
Luciana Gomes da Rocha
SOSilvando Carmo de Oliveira
Silvando Carmo de Oliveira
FMFernando Daniel de Oliveira Mayorga
Fernando Daniel de Oliveira Mayorga
Diane Isabelle Magno CavalcanteDiane Isabelle Magno Cavalcante
Diane Isabelle Magno Cavalcante
Introduction: Fine-needle aspiration or core needle biopsy guided by ultrasound of the axilla can provide crucial information for the treatment of breast cancer. Methods: This prospective phase 1 real-world study evaluated the effectiveness of the triple test, physical examination (PE), ultrasound (US), and ultrasound-guided fine-needle aspiration (USFNA) or ultrasound-guided core needle biopsy (USCNB) in predicting axillary metastases. It also explored the possibility of omitting axillary surgery based on negative results. The study included patients with high-penetrance mutations, ductal carcinoma in situ, or invasive breast cancer (cT1–4, axillary cN0–2), all of whom underwent aspiration or biopsy along with lymph node marking (using charcoal or clips), followed by sentinel lymph node biopsy and/or axillary dissection. Results: A total of 363 lymph nodes were dissected in 43 patients. The sensitivity of PE and US was 33.3% and 53.3%, respectively. When combining USFNA/USCNB with PE and US, sensitivity increased from 66.67% to 80%. Among patients with mutations or ductal carcinoma in situ or invasive cancer (cT1–4), when all three methods (PE, US, and USFNA/USCNB) were negative, the rate of positive lymph nodes was only 10%. Conclusions: Relying solely on PE, US, or USFNA/USCNB has limitations in detecting axillary metastases. Incorporating USFNA/USCNB significantly improved sensitivity and decreased false-negative rates. When all three methods were negative, the rate of axillary involvement was only 10%, indicating that axillary surgery could potentially be omitted. However, further studies are needed to validate these methods as reliable predictive tools for treatment decisions.